UFD4 Antibody

What is UFD4 and why is it important in ubiquitination research?

UFD4 is a HECT-type E3 ubiquitin ligase that plays a significant role in protein degradation pathways, particularly in the N-degron pathway. It preferentially ubiquitinates the proximal ubiquitin in K48-linked ubiquitin chains in a K29-linkage specific manner, creating branched ubiquitin chains . This specificity is critical for understanding targeted protein degradation mechanisms. The importance of UFD4 lies in its ability to augment polyubiquitination events on proteins with destabilizing N-terminal residues, thereby accelerating their degradation .

When designing experiments with UFD4 antibodies, researchers should consider that UFD4 functions in complex with Ubr1, a RING-type E3 ligase, to mediate both the Arg/N-end rule pathway and part of the UFD pathway . The collaboration between UFD4 and Ubr1 increases the processivity of polyubiquitination compared to either enzyme acting alone, making UFD4 antibodies valuable tools for investigating this cooperative mechanism .

What are the key structural features of UFD4 that antibodies might target?

UFD4 contains several distinct structural regions that could serve as epitopes for antibody recognition. The visible UFD4 scaffold consists of three primary regions: the armadillo-like (ARM) region (residues 163-706) composed of multiple repeating α-helices, the HECT domain that contains the N-lobe (residues 1097-1361) and C-lobe (residues 1361-1483), and the multihelix region (MHR) (residues 707-1097) that bridges the ARM region and HECT domain .

Specifically, within the ARM region, UFD4 contains specialized ubiquitin-interacting helical clusters (UIHC1, residues 263-301; UIHC2, residues 304-332) that are involved in binding K48-linked diubiquitin . The HECT domain C-lobe contains important functional elements including a helix (residues 1462-1475) and loop (residues 1433-1445) that position the donor ubiquitin . When selecting or evaluating UFD4 antibodies, researchers should consider which of these domains they wish to target based on their specific research questions.

How does UFD4 interact with Ubr1 and what regions are involved?

UFD4 directly interacts with Ubr1 both in vitro and in vivo, forming a complex that enhances the polyubiquitination of substrates in both the N-end rule and UFD pathways . This interaction has been confirmed through multiple experimental approaches, including coimmunoprecipitation with purified proteins and the split-ubiquitin technique for in vivo validation .

The Ubr1-interacting region of UFD4 has been mapped through a series of deletion studies. Particularly, a fragment of Ubr1 (residues 454-795), encompassing just 342 residues of the 1,950-residue protein, was found to interact with UFD4 . When designing experiments with UFD4 antibodies, researchers should be aware that antibodies targeting this interaction region might interfere with the UFD4-Ubr1 complex formation, potentially affecting experimental outcomes when studying cooperative ubiquitination.

How can I design experiments to study UFD4's preference for K29-linked ubiquitination?

To investigate UFD4's preference for K29-linked ubiquitination, researchers can design reconstitution experiments similar to those described in the literature. A comprehensive approach would involve setting up in vitro ubiquitination assays using purified components: the yeast ubiquitin-activating enzyme (E1) Uba1, the ubiquitin-conjugating enzyme (E2) Ubc4, UFD4 as the E3 ligase, and wild-type ubiquitin .

To specifically examine UFD4's linkage preferences, you can compare ubiquitination efficiency using various ubiquitin substrates:

• Monoubiquitin

• K29-linked diubiquitin

• K48-linked diubiquitin

• K48-linked chains of different lengths (di-, tri-, tetra-, and penta-ubiquitin)

The key experimental readout should focus on detecting higher polyubiquitination on K48-linked diubiquitin compared to monoubiquitin or K29-linked diubiquitin. Quantitatively, the enzymatic kinetics of UFD4 on K48-linked diubiquitin are approximately 4.2-fold faster than on monoubiquitin (0.021 μM/min versus 0.005 μM/min) . UFD4 antibodies are essential in these experiments for western blot detection and confirmation of UFD4 presence in reaction mixtures.

What techniques can I use to analyze the interaction between UFD4 and specific ubiquitin chain topologies?

For analyzing UFD4's interaction with different ubiquitin chain topologies, researchers can employ several complementary techniques:

• Ubiquitin Linkage-Specific Assays: Use lysine-to-arginine ubiquitin mutants (K6R, K11R, K27R, K29R, K33R, K48R, or K63R) in ubiquitination reactions. The significant reduction in polyubiquitination when using K29R mutant ubiquitin confirms the K29-linkage specificity of UFD4 .

• Mass Spectrometry Analysis: This technique can definitively identify the linkage types in the polyubiquitin chains generated by UFD4. Reports show that UFD4 predominantly creates K29-linkages (93%) when elongating ubiquitin chains .

• Modified Substrate Preparation: To distinguish between ubiquitination at proximal versus distal lysine residues, prepare K48-linked diubiquitin with mutations at either the proximal or distal K29 site (diUbK48prox* and diUbK48dist*). Comparing ubiquitination efficiency on these modified substrates can reveal preferences for specific positions .

• Cryo-EM Structural Analysis: For advanced studies, cryo-electron microscopy can visualize the structural basis of UFD4's interaction with ubiquitin chains, revealing how UFD4 positions itself to catalyze K29-linked ubiquitination specifically .

In these techniques, UFD4 antibodies are invaluable for immunoprecipitation, western blot detection, and potentially for structural studies using immunogold labeling.

How can I interpret contradictory data when studying UFD4 mutants?

When encountering contradictory data in UFD4 mutation studies, consider the following systematic approach:

First, examine the specific domains affected by the mutations. Different mutations in UFD4 have distinctly different effects on ubiquitination activity. For example:

• The UFD4 R1468A mutant in the helix (residues 1462-1475) almost completely eliminates ubiquitination activity

• The UFD4 E1442A mutant in the loop (residues 1433-1445) weakens activity by approximately 30%

• The double mutant D1436A/L1438A (DL mutant) reduces activity by about 50%

Second, consider potential combinatorial effects between UFD4 and ubiquitin mutations. Research shows that simultaneous mutations in both UFD4 and ubiquitin (e.g., UFD4 DL mutant with Ub I36A, or UFD4 E1442A with Ub L71A) can result in negligible ubiquitination activity, even when individual mutations have milder effects .

Third, use multiple detection methods to verify results. Combine biochemical assays with structural analyses to determine whether contradictory data arise from technical issues or reflect actual biological complexity. UFD4 antibodies specifically recognizing either wild-type or mutant forms can be particularly helpful in resolving such contradictions.

What are the optimal conditions for using UFD4 antibody in Western blotting?

When using UFD4 antibodies for Western blotting, several technical considerations can optimize results:

For sample preparation, given UFD4's role in ubiquitination pathways, it's crucial to include deubiquitinase inhibitors (such as N-ethylmaleimide or PR-619) in lysis buffers to preserve the ubiquitinated state of proteins. Additionally, consider using proteasome inhibitors (MG132) in cell culture before harvesting to increase the abundance of ubiquitinated proteins .

For the blotting procedure itself, researchers should note that UFD4 is a large protein (~167 kDa in yeast) that may require special transfer conditions, including longer transfer times or specialized buffers for large proteins. When detecting UFD4-mediated ubiquitination, a gradient gel (4-15% or 4-20%) can help resolve the ladder of polyubiquitinated products.

For optimal antibody dilution, start with 1:1000 for primary antibody incubation and adjust based on signal strength. To enhance specificity when studying UFD4-Ubr1 interactions, consider using dual-color Western blotting with differently tagged antibodies to simultaneously detect both proteins, similar to the approach used in coimmunoprecipitation studies with flag-tagged Ubr1 and ha-tagged UFD4 .

How can I validate the specificity of UFD4 antibody for my experiments?

Validating UFD4 antibody specificity is crucial for experimental reliability. A comprehensive validation approach includes:

Genetic Controls: Include samples from UFD4 knockout/knockdown cells or organisms as negative controls. The absence of signal in these samples confirms antibody specificity . Additionally, test the antibody against samples expressing UFD4 mutants with different domain deletions to confirm domain-specific recognition.

Peptide Competition Assay: Pre-incubate the UFD4 antibody with the peptide used as the immunogen. If the antibody is specific, this should block binding and eliminate signal in subsequent applications.

Immunoprecipitation-Mass Spectrometry: Perform immunoprecipitation with the UFD4 antibody followed by mass spectrometry to confirm that UFD4 is indeed the predominant protein being pulled down. This approach also reveals potential cross-reactive proteins.

Cross-reactivity Testing: If working across species, test the antibody against recombinant UFD4 from different species to determine cross-reactivity. The high conservation of HECT domain E3 ligases may result in cross-reactivity with related proteins, which should be carefully assessed .

Activity-Based Validation: For functional studies, verify that the antibody can detect UFD4's activity using in vitro ubiquitination assays with purified components, as described in the literature for studying UFD4's ubiquitination preferences .

What techniques are effective for studying UFD4's interaction with ubiquitin chains?

For studying UFD4's interaction with ubiquitin chains, several specialized techniques have proven effective:

Reconstituted Ubiquitination Assays: Set up in vitro reactions with purified components (E1, E2, UFD4, and ubiquitin variants) to study chain formation and linkage specificity. For quantitative analysis, use fluorescently labeled ubiquitin to track chain assembly kinetics, as demonstrated in studies showing UFD4's preference for K48-linked diubiquitin .

Ubiquitin Chain Restriction Analysis: Use linkage-specific deubiquitinating enzymes (DUBs) to cleave specific ubiquitin linkages and analyze the resulting products by Western blotting with UFD4 antibodies.

Cryo-EM Analysis with Crosslinked Complexes: For structural studies, synthesize activity-based probes like the Ubc4-Ub probe that can be crosslinked with UFD4 in an active center-dependent manner. This approach has yielded high-resolution structural information (3.52 Å maps) revealing how UFD4 interacts with ubiquitin chains .

Split-Ubiquitin Technique: For detecting protein interactions in vivo, the split-ubiquitin technique has successfully demonstrated UFD4's interaction with Ubr1. This method can be adapted to study UFD4's interaction with other proteins or modified ubiquitin chains .

When using UFD4 antibodies in these techniques, researchers should be mindful that antibody binding might interfere with protein interactions. Controls with Fab fragments or epitope mapping can help identify whether the antibody's binding site overlaps with important interaction surfaces.